SCHEMBL7346799

SCHEMBL7346799

O[C@H]1C=CCCC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7351338 1.00
SCHEMBL107504 1.00
Cyclohexene SCHEMBL8175251 0.95
SCHEMBL14612282 0.92
SCHEMBL1071594 0.92
Bicarbonate SCHEMBL5180989 0.90 POLB (0.31)
SCHEMBL25161927 0.89
SCHEMBL1535243 0.89 TSHR (0.32)
SCHEMBL1072262 0.89
SCHEMBL11613169 0.89 TSHR (0.32)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 37 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5278323-A Process for preparing chiral dibenzofurans via intramolecular heck reaction RHONE-POULENC RORER PHARMACEUTICALS INC. (US) 1994-01-11 US claimed
JP-4182453-A None JP disclosed
JP-4069375-A None JP disclosed
CN-118724665-A Method for constructing chiral alcohol by asymmetric hydrogenation of conjugated ketene 深圳格林凯特医药技术有限公司 2024-10-01 CN disclosed
US-20220380309-A1 CHOLINE METABOLISM INHIBITORS PRESIDENT AND FELLOWS OF HARVARD COLLEGE 2022-12-01 US disclosed
WO-2020117942-A1 CHOLINE METABOLISM INHIBITORS PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) 2020-06-11 WO disclosed
WO-2020117942-A1 CHOLINE METABOLISM INHIBITORS PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) 2020-06-11 WO disclosed
US-9937186-B2 Sulfonamides derived from tricyclyl-2-aminocycloalkanols as anticancer agents ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI (US) 2018-04-10 US disclosed
US-9937186-B2 Sulfonamides derived from tricyclyl-2-aminocycloalkanols as anticancer agents ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI (US) 2018-04-10 US disclosed
EP-3116860-B1 SULFONAMIDES DERIVED FROM TRICYCLYL-2-AMINOCYCLOALKANOLS AS ANTICANCER AGENTS ICAHN SCHOOL MED MOUNT SINAI (US) 2018-02-07 EP disclosed
EP-0559656-A1 PROCESS FOR PREPARING MULTICYCLIC OXY-CONTAINING RING COMPONENTS RHONE-POULENC RORER INTERNATIONAL (HOLDINGS) INC. (US) 1993-09-15 EP disclosed
JP-H04182453-A OPTICALLY ACTIVE CYCLOHEXYL CARBOXYLATE DERIVATIVE AND ITS PRODUCTION SANKYO CO LTD 1992-06-30 JP disclosed
WO-1992009592-A1 PROCESS FOR PREPARING MULTICYCLIC OXY-CONTAINING RING COMPONENTS RHONE-POULENC RORER INTERNATIONAL (HOLDINGS) INC. (US) 1992-06-11 WO disclosed
JP-H0469375-A OPTICALLY ACTIVE CYCLOHEXYLCARBOXYLATE AND ITS PRODUCTION SANKYO CO LTD 1992-03-04 JP disclosed
CN-1050386-A Indoles and benzo quinoline, their preparation and they are as anti-arrhythmic SANKYO CO (JP) 1991-04-03 CN disclosed
EP-0415776-A2 Indolobenzoquinoline derivatives, their preparation and their use as anti-arrhythmic drugs Sankyo Company Limited (JP) 1991-03-06 EP disclosed
EP-0345689-A2 Process for the preparation of alpha, beta unsaturated alcohols CIBA-GEIGY AG (CH) 1989-12-13 EP disclosed
EP-0161904-B1 TETRAHYDROFURANYL AND TETRAHYDROTHIENYL SUBSTITUTED ETHERS E.R. Squibb &amp; Sons, Inc. (US) 1989-10-18 EP disclosed
EP-0161904-A2 Tetrahydrofuranyl and tetrahydrothienyl substituted ethers E.R. Squibb &amp; Sons, Inc. (US) 1985-11-21 EP disclosed
US-4521539-A ANALGESICS, CARDIONVASCULAR AND ANTIINFLAMMATORY AGENTS E. R. SQUIBB & SONS, INC. (US) 1985-06-04 US disclosed